Inter-firm R&D partnering in pharmaceutical biotechnology since 1975: Trends, patterns, and networks

被引:157
|
作者
Roijakkers, N
Hagedoorn, J
机构
[1] Eindhoven Univ Technol, Dept Org Sci & Mkt, Fac Technol Management, NL-5600 MB Eindhoven, Netherlands
[2] Eindhoven Univ Technol, ECIS, Fac Technol Management, NL-5600 MB Eindhoven, Netherlands
[3] Maastricht Univ, Fac Econ & Business Adm, Dept Org & Strategy, NL-6200 MD Maastricht, Netherlands
[4] Maastricht Univ, Fac Econ & Business Adm, MERIT, NL-6200 MD Maastricht, Netherlands
关键词
R&D partnerships; research networks; pharmaceutical biotechnology; network visualization software;
D O I
10.1016/j.respol.2006.01.006
中图分类号
C93 [管理学];
学科分类号
12 ; 1201 ; 1202 ; 120202 ;
摘要
This paper analyses a large, longitudinal database on inter-firm R&D partnerships formed in the high-tech pharmaceutical biotechnology industry since 1975. Our research indicates an overall growth in the number of annually, newly established R&D partnerships where research partners consistently prefer contractual partnerships to equity-based alliances. In the networks that develop through these R&D partnerships, small, entrepreneurial biotechnological companies take a leading role during the 1980s, when biotechnology first became relevant for the pharmaceutical industry. The 1990s, however, show a different pattern with established, large pharmaceutical companies becoming more dominant, acting as nodal players with multiple partnerships with a variety of other companies. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:431 / 446
页数:16
相关论文
共 50 条
  • [41] Unpacking the effects of R&D strategy proximity on inter-firm knowledge flow: evidence from the global 3D printing industry
    Xu, Guannan
    Kang, Ning
    Hu, Weijie
    Islam, Nazrul
    Zhou, Yuan
    TECHNOLOGY ANALYSIS & STRATEGIC MANAGEMENT, 2024,
  • [42] R&D and firm performance: evidence from the Indian pharmaceutical industry
    Sharma, Chandan
    JOURNAL OF THE ASIA PACIFIC ECONOMY, 2012, 17 (02) : 332 - 342
  • [43] Trends in pharmaceutical company R&D spending: 2005–2015
    Richa Dixit
    Frank S. David
    Nature Reviews Drug Discovery, 2017, 16 : 376 - 376
  • [44] WHAT DRIVES ENTERPRISE PRODUCT INNOVATION? ASSESSING HOW REGIONAL, NATIONAL, AND INTERNATIONAL INTER-FIRM COLLABORATION COMPLEMENT OR SUBSTITUTE FOR R&D INVESTMENTS
    Aarstad, Jarle
    Kvitastein, Olav Andreas
    Jakobsen, Stig-Erik
    INTERNATIONAL JOURNAL OF INNOVATION MANAGEMENT, 2019, 23 (05)
  • [45] R&D and regional networks dynamics in Dutch pharmaceutical industry
    VanGeenhuizen, M
    VanderKnaap, B
    TIJDSCHRIFT VOOR ECONOMISCHE EN SOCIALE GEOGRAFIE, 1997, 88 (04) : 307 - 320
  • [46] Assessing the impact of current trends in genomics on the future of pharmaceutical R&D
    Arlington, S
    Peakman, T
    DRUG DISCOVERY TODAY, 2001, 6 (04) : 161 - 162
  • [47] Microfoundations of Firm R&D Capabilities: A Study of Inventor Networks in a Merger
    Paruchuri, Srikanth
    Eisenman, Micki
    JOURNAL OF MANAGEMENT STUDIES, 2012, 49 (08) : 1509 - 1535
  • [48] Evolution of R&D capabilities: The role of knowledge networks within a firm
    Nerkar, A
    Paruchuri, S
    MANAGEMENT SCIENCE, 2005, 51 (05) : 771 - 785
  • [49] Inter-temporal patterns of R&D collaboration and innovative performance
    Belderbos, Ren
    Carree, Martin
    Lokshin, Boris
    Fernandez Sastre, Juan
    JOURNAL OF TECHNOLOGY TRANSFER, 2015, 40 (01): : 123 - 137
  • [50] Inter-temporal patterns of R&D collaboration and innovative performance
    René Belderbos
    Martin Carree
    Boris Lokshin
    Juan Fernández Sastre
    The Journal of Technology Transfer, 2015, 40 : 123 - 137